Nucleosides

2'-Modified Nucleosides
(288/288)
3'-Modified Nucleosides
(157/157)
5'-Modified Nucleosides
(236/236)
Anhydro-Nucleosides
(13/13)
Arabinonucleosides
(34/34)
Base Protected Nucleosides
(224/224)
Halogen Nucleosides
(134/134)
L-Nucleosides
(18/18)
Other Nucleosides
(77/77)
Other Protected Nucleosides
(23/23)
Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All

5'-O-(4,4'-Dimethoxytrityl)-N2-dimethylformamidine-2'-fluoro-2'-deoxyguanosine

Description: 5'-O-(4,4'-Dimethoxytrityl)-N2-dimethylformamidine-2'-fluoro-2'-deoxyguanosine is a chemically modified nucleoside used in oligonucleotide synthesis. This nucleoside features a 5'-O-(4,4'-Dimethoxytrityl) protecting group on the 5' hydroxyl, a N2-dimethylformamidine group at the guanosine base, and a 2'-fluoro modification on the deoxyribose sugar. It is employed to enhance stability and specificity in oligonucleotide design, particularly useful for developing therapeutic oligonucleotides like antisense oligonucleotides and siRNAs, and for conducting research on nucleic acid interactions and structure-function relationships.
CAT: BRP-01548
CAS: 2377586-41-7
MF: C34H35FN6O6
MF: 642.68
Purity: ≥98% by HPLC
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
Density: 1.35±0.1 g/cm3
Boiling Point: 839.5±75.0 °C at 760 mmHg
InChIKey: YYXHJLCVHPOJDK-UUEOAETPSA-N
CanonicalSMILES: CN(C)C=NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)F
IUPAC Name: N'-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
InChI: InChI=1S/C34H35FN6O6/c1-40(2)19-37-33-38-30-28(31(43)39-33)36-20-41(30)32-27(35)29(42)26(47-32)18-46-34(21-8-6-5-7-9-21,22-10-14-24(44-3)15-11-22)23-12-16-25(45-4)17-13-23/h5-17,19-20,26-27,29,32,42H,18H2,1-4H3,(H,38,39,43)/t26-,27-,29-,32-/m1/s1
Synonyms: N2-dmf-DMT-2'-F-dG; 5'-O-DMT-N2-dimethylformamide-2'-fluoro-2'-deoxyguanosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-N-[(dimethylamino)methylene]guanosine; N'-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-N,N-dimethylformimidamide

N1-Methylene pivalate-N2-dibutylformamidine-2'-fluoro-guanosine

Description: N1-Methylene pivalate-N2-dibutylformamidine-2'-fluoro-guanosine is a modified guanosine nucleoside designed with protective groups at the N1 and N2 positions, alongside a 2'-fluoro modification on the ribose, enhancing stability and resistance to enzymatic degradation. This compound is pivotal in synthesizing modified oligonucleotides for biomedical research, improving nucleic acid performance in applications like gene therapy and molecular diagnostics.
CAT: BRP-01563
MF: C25H39FN6O6
MF: 538.62
Purity: ≥95% by HPLC
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
InChIKey: OSNSETGWWMLVPD-VALFRTSSSA-N
IUPAC Name: (2-(((dibutylamino)methylene)amino)-9-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-1-yl)methyl pivalate
InChI: InChI=1S/C25H39FN6O6/c1-6-8-10-30(11-9-7-2)13-28-24-29-20-18(21(35)32(24)15-37-23(36)25(3,4)5)27-14-31(20)22-17(26)19(34)16(12-33)38-22/h13-14,16-17,19,22,33-34H,6-12,15H2,1-5H3/t16-,17-,19-,22-/m1/s1
Synonyms: N1-methylene pivalate-N2-dibutylformamidine-2'-F-Gr

N4-Dibutylformamidine-2'-fluoro-deoxycytidine

Description: N4-Dibutylformamidine-2'-fluoro-deoxycytidine is a modified deoxycytidine nucleoside featuring a dibutylformamidine group at the N4 position and a 2'-fluoro modification on the deoxyribose sugar, enhancing stability and enzymatic resistance in oligonucleotide synthesis, crucial for biomedical applications like gene therapy and molecular diagnostics.
CAT: BRP-01564
MF: C18H29FN4O4
MF: 384.45
Purity: ≥95% by HPLC
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
InChIKey: LALGLRQWGPDIIJ-MWQQHZPXSA-N
IUPAC Name: N,N-dibutyl-N'-(1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)formimidamide
InChI: InChI=1S/C18H29FN4O4/c1-3-5-8-22(9-6-4-2)12-20-14-7-10-23(18(26)21-14)17-15(19)16(25)13(11-24)27-17/h7,10,12-13,15-17,24-25H,3-6,8-9,11H2,1-2H3/t13-,15-,16-,17-/m1/s1
Synonyms: N4-dibutylformamidine-2'-F-dC

N2-Dibutylformamidine-2'-fluoro-guanosine

Description: N2-Dibutylformamidine-2'-fluoro-guanosine is a modified guanosine nucleoside with a dibutylformamidine group attached to the N2 position and a 2'-fluoro modification on the ribose, enhancing stability and enzymatic resistance in oligonucleotide synthesis, crucial for biomedical applications like gene therapy and molecular diagnostics.
CAT: BRP-01565
MF: C19H29FN6O4
MF: 424.48
Purity: ≥95% by HPLC
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
InChIKey: XMWCLGNFTGLYEX-HOPMXRPOSA-N
IUPAC Name: N,N-dibutyl-N'-(9-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)formimidamide
InChI: InChI=1S/C19H29FN6O4/c1-3-5-7-25(8-6-4-2)10-22-19-23-16-14(17(29)24-19)21-11-26(16)18-13(20)15(28)12(9-27)30-18/h10-13,15,18,27-28H,3-9H2,1-2H3,(H,23,24,29)/t12-,13-,15-,18-/m1/s1
Synonyms: N2-dibutylformamidine-2'-F-Gr

N2-Acetyl-5'-O-(4,4'-dimethoxytrityl)-2'-fluoro-deoxyguanosine

Description: N2-Acetyl-5'-O-(4,4'-dimethoxytrityl)-2'-fluoro-deoxyguanosine is a modified deoxyguanosine nucleoside with an acetyl group at the N2 position and a 2'-fluoro modification on the deoxyribose sugar, protected by a 4,4'-dimethoxytrityl (DMTr) group at the 5'-hydroxyl. This modification enhances stability and enzymatic resistance in oligonucleotide synthesis, essential for biomedical applications such as gene therapy and molecular diagnostics.
CAT: BRP-01566
CAS: 514830-14-9
MF: C33H32FN5O7
MF: 629.63
Purity: ≥95% by HPLC
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
InChIKey: JKJYAEOBEUHFSL-IAHIMPAPSA-N
CanonicalSMILES: CC(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)F
IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]acetamide
InChI: InChI=1S/C33H32FN5O7/c1-19(40)36-32-37-29-27(30(42)38-32)35-18-39(29)31-26(34)28(41)25(46-31)17-45-33(20-7-5-4-6-8-20,21-9-13-23(43-2)14-10-21)22-11-15-24(44-3)16-12-22/h4-16,18,25-26,28,31,41H,17H2,1-3H3,(H2,36,37,38,40,42)/t25-,26-,28-,31-/m1/s1
Synonyms: N2-Ac-DMT-2'-F-dG; N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide; Guanosine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-; N-Acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroguanosine

N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-3'-O-succinate-2'-fluoro-deoxyguanosine, triethylamine salt

Description: N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-3'-O-succinate-2'-fluoro-deoxyguanosine, triethylamine salt is a modified deoxyguanosine nucleoside. It features an isobutyryl group at the N2 position, a 4,4'-dimethoxytrityl (DMTr) group at the 5'-hydroxyl, a succinate ester at the 3'-hydroxyl, and a 2'-fluoro modification on the deoxyribose sugar. This compound, in its triethylamine salt form, enhances stability and enzymatic resistance in oligonucleotide synthesis, crucial for applications such as gene therapy and molecular diagnostics.
CAT: BRP-01572
MF: C45H55FN6O10
MF: 858.95
Purity: ≥98% by HPLC
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at RT
InChIKey: JAFGAGVWXBMKKQ-KYJIEUEGSA-N
CanonicalSMILES: O=C1N=C(NC(=O)C(C)C)NC2=C1N=CN2C3OC(COC(C=4C=CC=CC4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)C(OC(=O)CCC(=O)O)C3F.N(CC)(CC)CC
IUPAC Name: 4-(((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluoro-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl)oxy)-4-oxobutanoic acid;N,N-diethylethanamine
InChI: InChI=1S/C39H40FN5O10.C6H15N/c1-22(2)35(49)43-38-42-34-32(36(50)44-38)41-21-45(34)37-31(40)33(55-30(48)19-18-29(46)47)28(54-37)20-53-39(23-8-6-5-7-9-23,24-10-14-26(51-3)15-11-24)25-12-16-27(52-4)17-13-25;1-4-7(5-2)6-3/h5-17,21-22,28,31,33,37H,18-20H2,1-4H3,(H,46,47)(H2,42,43,44,49,50);4-6H2,1-3H3/t28-,31-,33-,37-;/m1./s1
Synonyms: N2-iBu-DMT-2'-F-dG-3'-succinate, TEA salt; 5'-DMT-2'-F-dG(iBu)-3'-succinate, TEA salt; 5'-DMT-NIBu-2'-F-dG-3'-succinate, TEA salt; 5'-O-(4,4'-Dimethoxytrityl)-N2-isobutyryl-2'-fluoro-deoxyguanosine-3'-O-succinate, triethylamine salt

N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-succinate-2'-fluoro-deoxyadenosine, triethylamine salt

Description: N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-succinate-2'-fluoro-deoxyadenosine, triethylamine salt is a modified deoxyadenosine nucleoside. It features a benzoyl group at the N6 position, a 4,4'-dimethoxytrityl (DMTr) group at the 5'-hydroxyl, a succinate ester at the 3'-hydroxyl, and a 2'-fluoro modification on the deoxyribose sugar. This compound, in its triethylamine salt form, enhances stability and enzymatic resistance in oligonucleotide synthesis, crucial for applications such as gene therapy and molecular diagnostics.
CAT: BRP-01573
MF: C48H53FN6O9
MF: 876.97
Purity: ≥98% by HPLC
Appearance: White to yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C
InChIKey: RVRGUAZPBXTGSP-ARCYALSHSA-N
CanonicalSMILES: O=C(O)CCC(=O)OC1C(F)C(OC1COC(C=2C=CC=CC2)(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4)N5C=NC=6C(=NC=NC65)NC(=O)C=7C=CC=CC7.N(CC)(CC)CC
IUPAC Name: 4-(((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl)oxy)-4-oxobutanoic acid;N,N-diethylethanamine
InChI: InChI=1S/C42H38FN5O9.C6H15N/c1-53-30-17-13-28(14-18-30)42(27-11-7-4-8-12-27,29-15-19-31(54-2)20-16-29)55-23-32-37(57-34(51)22-21-33(49)50)35(43)41(56-32)48-25-46-36-38(44-24-45-39(36)48)47-40(52)26-9-5-3-6-10-26;1-4-7(5-2)6-3/h3-20,24-25,32,35,37,41H,21-23H2,1-2H3,(H,49,50)(H,44,45,47,52);4-6H2,1-3H3/t32-,35-,37-,41-;/m1./s1
Synonyms: N6-Bz-DMT-2'-F-dA-3'-succinate, TEA salt; 5'-O-(4,4'-Dimethoxytrityl)-N6-benzoyl-2'-deoxyadenoisne-3'-O-succinate, triethylamine salt; 5'-DMT-NBz-2'-dA-3'-succinate, TEA salt

N4-Acetyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-succinate-2'-fluoro-deoxycytidine, triethylamine salt

Description: N4-Acetyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-succinate-2'-fluoro-deoxycytidine, triethylamine salt is a modified deoxycytidine nucleoside. It features an acetyl group at the N4 position, a 4,4'-dimethoxytrityl (DMTr) group at the 5'-hydroxyl, a succinate ester at the 3'-hydroxyl, and a 2'-fluoro modification on the deoxyribose sugar. This compound, in its triethylamine salt form, enhances stability and enzymatic resistance in oligonucleotide synthesis, crucial for applications such as gene therapy and molecular diagnostics.
CAT: BRP-01574
MF: C42H51FN4O10
MF: 790.87
Purity: ≥98% by HPLC
Appearance: White to yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C
InChIKey: GGLFHSJASYEZGI-PBJRKIRISA-N
CanonicalSMILES: CCN(CC)CC.CC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OC(=O)CCC(=O)O)F
IUPAC Name: 4-[(2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-fluorooxolan-3-yl]oxy-4-oxobutanoic acid;N,N-diethylethanamine
InChI: InChI=1S/C36H36FN3O10.C6H15N/c1-22(41)38-29-19-20-40(35(45)39-29)34-32(37)33(50-31(44)18-17-30(42)43)28(49-34)21-48-36(23-7-5-4-6-8-23,24-9-13-26(46-2)14-10-24)25-11-15-27(47-3)16-12-25;1-4-7(5-2)6-3/h4-16,19-20,28,32-34H,17-18,21H2,1-3H3,(H,42,43)(H,38,39,41,45);4-6H2,1-3H3/t28-,32-,33-,34-;/m1./s1
Synonyms: N4-Ac-DMT-2'-F-dC-3'-succinate, TEA salt; 5'-O-(4,4'-Dimethoxytrityl)-N4-acetyl-3'-O-succinate-2'-fluoro-deoxycytidine, triethylamine salt; 5'-DMT-N4-Ac-2'-F-dC-3'-succinate, TEA salt; Triethylamine 4-(((2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl)oxy)-4-oxobutanoate
Related CAS: 2746380-45-8 (free base)

5'-O-DMT-3'-O-succinate-2'-F-deoxyuridine, triethylamine salt

Description: 5'-O-DMT-3'-O-succinate-2'-F-deoxyuridine, triethylamine salt is a modified deoxyuridine nucleoside. It features a 5'-dimethoxytrityl (DMT) group at the 5'-hydroxyl, a succinate ester at the 3'-hydroxyl, and a fluorine atom (2'-F) modification on the deoxyribose sugar. This compound, in its triethylamine salt form, enhances stability and enzymatic resistance in oligonucleotide synthesis, making it valuable for applications such as gene therapy and molecular diagnostics.
CAT: BRP-01575
CAS: 2294880-79-6
MF: C40H48FN3O10
MF: 749.82
Purity: ≥98% by HPLC
Appearance: White to yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C
InChIKey: ZLUXDOSHTOAICW-GNGCXMSBSA-N
CanonicalSMILES: CCN(CC)CC.COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=O)NC5=O)F)OC(=O)CCC(=O)O
IUPAC Name: 4-[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-3-yl]oxy-4-oxobutanoic acid;N,N-diethylethanamine
InChI: InChI=1S/C34H33FN2O10.C6H15N/c1-43-24-12-8-22(9-13-24)34(21-6-4-3-5-7-21,23-10-14-25(44-2)15-11-23)45-20-26-31(47-29(41)17-16-28(39)40)30(35)32(46-26)37-19-18-27(38)36-33(37)42;1-4-7(5-2)6-3/h3-15,18-19,26,30-32H,16-17,20H2,1-2H3,(H,39,40)(H,36,38,42);4-6H2,1-3H3/t26-,30-,31-,32-;/m1./s1
Synonyms: DMT-2'-F-dU-3'-succinate, TEA salt; 5'-O-(4,4'-dimethoxytrityl)-3'-O-succinate-2'-fluoro-deoxyuridine, triethylamine salt; Triethylamine 4-(((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl)oxy)-4-oxobutanoate; 5'-O-(4,4'-Dimethoxytrityl)-2'-fluoro-deoxyuridine 3'-O-succinate, triethylamine salt; 5'-DMT-2'-F-dU-3'-succinate, TEA salt
Related CAS: 2294880-67-2 (free base)

1-(2-Fluoro-2-deoxy-β-L-arabinofuranosyl)cytosine

Description: 1-(2-Fluoro-2-deoxy-β-L-arabinofuranosyl)cytosine is a modified nucleoside where cytosine is attached to a β-L-arabinofuranosyl sugar with a 2-fluoro-2-deoxy modification. This modification enhances the stability and alters the chemical properties of the nucleoside, making it useful in nucleic acid chemistry for applications such as nucleotide analog synthesis and structural studies.
CAT: BRP-01592
CAS: 163686-35-9
MF: C9H12FN3O4
MF: 245.21
Purity: ≥98%
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.82±0.1 g/cm3
Boiling Point: 500.1±60.0 °C at 760 mmHg
InChIKey: NVZFZMCNALTPBY-UCVXFZOQSA-N
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)F
IUPAC Name: 4-amino-1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C9H12FN3O4/c10-6-7(15)4(3-14)17-8(6)13-2-1-5(11)12-9(13)16/h1-2,4,6-8,14-15H,3H2,(H2,11,12,16)/t4-,6+,7-,8-/m0/s1
Synonyms: 2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)-; L-2'-F-Ara-Cytidine; 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl) cytosine; 4-amino-1-((2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 4-Amino-1-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)-2(1H)-pyrimidinone

9-(2'-Fluoro-2'-deoxy-β-L-arabinofuranosyl)adenine

Description: 9-(2'-Fluoro-2'-deoxy-β-L-arabinofuranosyl)adenine is a modified nucleoside where adenine is attached to a β-L-arabinofuranosyl sugar with a 2'-fluoro-2'-deoxy modification at the ribose. This modification enhances the stability and alters the chemical properties of the nucleoside, making it useful in nucleic acid chemistry for applications such as nucleotide analog synthesis and structural studies.
CAT: BRP-01593
CAS: 193754-07-3
MF: C10H12FN5O3
MF: 269.23
Purity: ≥98%
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 2.01±0.1 g/cm3
Boiling Point: 628.6±65.0 °C at 760 mmHg
InChIKey: ZGYYPTJWJBEXBC-JZWIFLOVSA-N
CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)F)N
IUPAC Name: (2S,3S,4R,5S)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
InChI: InChI=1S/C10H12FN5O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5+,7-,10-/m0/s1
Synonyms: L-2'-F-Ara-Adenosine; 9-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)adenine; (2S,3S,4R,5S)-5-(6-aminopurin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol; 9-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)-9H-purin-6-amine; 9H-Purin-6-amine, 9-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)-

9-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)guanine

Description: 9-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)guanine is a modified nucleoside where guanine is attached to a β-L-arabinofuranosyl sugar with a 2-deoxy-2-fluoro modification. This modification enhances the stability and alters the chemical properties of the nucleoside, making it useful in nucleic acid chemistry for applications such as nucleotide analog synthesis and structural studies.
CAT: BRP-01594
CAS: 193754-19-7
MF: C10H12FN5O4
MF: 285.23
Purity: ≥98%
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 2.17±0.1 g/cm3
Boiling Point: 726.1±70.0 °C at 760 mmHg
InChIKey: UXUZARPLRQRNNX-LSSUFRDISA-N
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(NC2=O)N
IUPAC Name: 2-amino-9-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C10H12FN5O4/c11-4-6(18)3(1-17)20-9(4)16-2-13-5-7(16)14-10(12)15-8(5)19/h2-4,6,9,17-18H,1H2,(H3,12,14,15,19)/t3-,4+,6-,9-/m0/s1
Synonyms: L-2'-F-Ara-Guanosine; 9-(2-Fluoro-2-deoxy-β-L-arabinofuranosyl)guanine; 6H-Purin-6-one, 2-amino-9-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)-3,9-dihydro-; 2-Amino-9-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)-3,9-dihydro-6H-purin-6-one; 2-amino-9-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-ol; 6H-Purin-6-one, 2-amino-9-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)-1,9-dihydro-; 2-Amino-9-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)-1,9-dihydro-6H-purin-6-one

1-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)uracil

Description: 1-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)uracil is a modified nucleoside where uracil is attached to a β-L-arabinofuranosyl sugar with a 2-deoxy-2-fluoro modification. This modification enhances the stability and alters the chemical properties of the nucleoside, making it useful in nucleic acid chemistry for applications such as nucleotide analog synthesis and structural studies.
CAT: BRP-01595
CAS: 1312300-54-1
MF: C9H11FN2O5
MF: 246.19
Purity: ≥98%
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.63±0.1 g/cm3
InChIKey: UIYWFOZZIZEEKJ-UCVXFZOQSA-N
CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F
IUPAC Name: 1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8-/m0/s1
Synonyms: 1-((2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 2'-Deoxy-2'-fluoro-beta-L-arabinouridine; 1-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)-2,4(1H,3H)-pyrimidinedione; 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)-; 2'-Fluoro-5-ethyl-1-β-L-arabinofuranosyluracil

N,2'-O,3'-O-Triacetylcytidine

Description: N,2'-O,3'-O-Triacetylcytidine is an exceptional biomedical product, used for studying conspicuous viral infections, such as hepatitis C and influenza. It has the remarkable ability to impede viral RNA replication.
CAT: BRP-01628
CAS: 40632-06-2
MF: C15H19N3O8
MF: 369.33
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
Density: 1.53±0.1 g/cm3
InChIKey: PWCGIZSEUGLASX-FMKGYKFTSA-N
CanonicalSMILES: CC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)OC(=O)C)OC(=O)C
IUPAC Name: [(2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1-yl)-4-acetyloxy-2-(hydroxymethyl)oxolan-3-yl] acetate
InChI: InChI=1S/C15H19N3O8/c1-7(20)16-11-4-5-18(15(23)17-11)14-13(25-9(3)22)12(24-8(2)21)10(6-19)26-14/h4-5,10,12-14,19H,6H2,1-3H3,(H,16,17,20,23)/t10-,12-,13-,14-/m1/s1
Synonyms: N4-acetyl-2',3'-diacetyl-cytidine; 2',3'-diAc-C(Ac); Cytidine, N-acetyl-, 2',3'-diacetate; (2R,3R,4R,5R)-2-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diyl diacetate; N-Acetyl-2',3'-di-O-acetylcytidine

5'-O-(4,4'-Dimethoxytrityl)-N2-isobutyryl-2'-O,4'-C-methyleneguanosine

Description: 5'-O-(4,4'-Dimethoxytrityl)-N2-isobutyryl-2'-O,4'-C-methyleneguanosine is a revolutionary biomedical substance renowned for its remarkable antiviral and antiproliferative attributes.
CAT: BRP-01629
CAS: 206055-72-3
MF: C36H37N5O8
MF: 667.71
Purity: ≥95%
Appearance: Off-white to yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
Density: 1.41±0.1 g/cm3
InChIKey: JMGQUFRCVHVMAX-UBMDZZGASA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C4C(C(O3)(CO4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)O
IUPAC Name: N-[9-[(1R,3R,4R,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C36H37N5O8/c1-21(2)31(43)39-34-38-30-27(32(44)40-34)37-20-41(30)33-28-29(42)35(49-33,18-47-28)19-48-36(22-8-6-5-7-9-22,23-10-14-25(45-3)15-11-23)24-12-16-26(46-4)17-13-24/h5-17,20-21,28-29,33,42H,18-19H2,1-4H3,(H2,38,39,40,43,44)/t28-,29+,33-,35-/m1/s1
Synonyms: N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-O-4'-C-Locked-guanosine; N2-iBu-DMT-2'-O-4'-C-Locked-Gr; N-(9-{(1R,3R,4R,7S)-1-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-7-hydroxy-2,5-dioxa-bicyclo[2.2.1]hept-3-yl}-6-oxo-6,9-dihydro-1H-purin-2-yl)-isobutyramide; Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O,4'-C-methylene-N-(2-methyl-1-oxopropyl)-; (1R,3R,4R,7S)-1-(4,4'-Dimethoxytrityloxymethyl)-7-hydroxy-3-(2-N-isobutyrylguanin-9-yl)-2,5-dioxabicyclo[2.2.1]heptane

N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-5-methyl-2'-O,4'-C-methylenecytidine

Description: N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-5-methyl-2'-O,4'-C-methylenecytidine, a highly potent compound extensively employed in the biomedical field, exhibits exceptional efficacy in combatting viral infections. This compound particularly exhibits remarkable proficiency against RNA viruses, such as SARS-CoV-2, ensuring its pervasive usefulness. By engaging viral RNA polymerase, it effectively impedes viral replication, thereby portraying its indispensable antiviral attributes.
CAT: BRP-01630
CAS: 445012-77-1
MF: C39H37N3O8
MF: 675.73
Purity: ≥98% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, in tightly closed container, protected from light and humidity
Density: 1.32±0.1 g/cm3
InChIKey: CTGWFRQUULNNIN-OSZGUBSQSA-N
CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C4C(C(O3)(CO4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)O
IUPAC Name: N-(1-((1R,3R,4R,7S)-1-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
InChI: InChI=1S/C39H37N3O8/c1-25-22-42(37(45)41-34(25)40-35(44)26-10-6-4-7-11-26)36-32-33(43)38(50-36,23-48-32)24-49-39(27-12-8-5-9-13-27,28-14-18-30(46-2)19-15-28)29-16-20-31(47-3)21-17-29/h4-22,32-33,36,43H,23-24H2,1-3H3,(H,40,41,44,45)/t32-,33+,36-,38-/m1/s1
Synonyms: N4-benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-4'-C-Locked-5-methyl-cytidine; N-(1-((1R,3R,4R,7S)-1-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide; Benzamide, N-[1-[2,5-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-α-L-lyxofuranosyl]-1,2-dihydro-5-methyl-2-oxo-4-pyrimidinyl]-; N-[1-[2,5-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-α-L-lyxofuranosyl]-1,2-dihydro-5-methyl-2-oxo-4-pyrimidinyl]benzamide; N4-Bz-DMT-2'-O-4'-C-Locked-5-Me-Cr

N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine

Description: N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine, a recently developed cytidine derivative, exhibits potential application in treating various diseases, such as cancer and viral infections, by suppressing malignancy and viral proliferation whilst preserving normal cells. With its unique mechanism, this product may have a significant impact in the combat of severe afflictions.
CAT: BRP-01631
CAS: 741725-57-5
MF: C39H39N3O8
MF: 677.76
Purity: ≥98% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
Density: 1.26±0.1 g/cm3 (Predicted)
InChIKey: BUUDDUQHVVDKLA-TUDCZORBSA-N
CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OC
IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
InChI: InChI=1S/C39H39N3O8/c1-25-23-42(38(45)41-35(25)40-36(44)26-11-7-5-8-12-26)37-34(48-4)33(43)32(50-37)24-49-39(27-13-9-6-10-14-27,28-15-19-30(46-2)20-16-28)29-17-21-31(47-3)22-18-29/h5-23,32-34,37,43H,24H2,1-4H3,(H,40,41,44,45)/t32-,33-,34-,37-/m1/s1
Synonyms: N4-benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-5-methyl-Cytidine; DMT-2'-O-Me-5-Me-C(Bz); 5'-O-DMT-2'-OMe-N4-Bz-5-Me-C; N4-Benzoyl-5-methyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-cytidine; 5'-O-(4,4'-Dimethoxytrityl)-N4-Benzoyl-2'-O-Methy-5-MethyCytidine; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-5-methyl-2'-O-methylcytidine; N4-Benzoyl-5'-O-DMT-2'-O-methyl-5-methylcytidine

5'-O-(Dimethoxytrityl)-2'-O-methylinosine

Description: 5'-O-(Dimethoxytrityl)-2'-O-methylinosine is an indispensable compound employed in the biomedical industry, showcasing considerable promise as a research tool for diverse afflictions and maladies. With profound implications in drug development, it enables the precise modulation of molecular pathways and gene expressions. The multifaceted utilization of this compound extends to the realm of research of cancer, viral infections and neurological impairments.
CAT: BRP-01633
CAS: 128219-84-1
MF: C32H32N4O7
MF: 584.63
Purity: ≥97% by HPLC
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
Density: 1.35±0.1 g/cm3
Boiling Point: 841.8±65.0 °C at 760 mmHg
InChIKey: KXFBGUCGEWPHRA-QWOIFIOOSA-N
CanonicalSMILES: COC1C(C(OC1N2C=NC3=C2N=CNC3=O)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O
IUPAC Name: 9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C32H32N4O7/c1-39-23-13-9-21(10-14-23)32(20-7-5-4-6-8-20,22-11-15-24(40-2)16-12-22)42-17-25-27(37)28(41-3)31(43-25)36-19-35-26-29(36)33-18-34-30(26)38/h4-16,18-19,25,27-28,31,37H,17H2,1-3H3,(H,33,34,38)/t25-,27-,28-,31-/m1/s1
Synonyms: 5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-inosine; DMT-2'-OMe-Ir; 5'-O-Dmt-2'-O-methyl-inosine; Inosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-; 9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one

5'-O-DMT-2'-O-methylguanosine

Description: 5'-O-DMT-2'-O-methylguanosine, a nucleoside analogue, finds its purpose in biomedical research due to its potential antiviral activity against RNA viruses, an area of significant scientific interest. Its inhibitory role in the replication of notorious viruses such as Zika virus and hepatitis C virus warrants further academic study.
CAT: BRP-01634
CAS: 103285-24-1
MF: C32H33N5O7
MF: 599.65
Purity: ≥98% by HPLC
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.40±0.1 g/cm3
InChIKey: AYVWAUNZRMANQB-BQOYKFDPSA-N
CanonicalSMILES: COC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O
IUPAC Name: 2-amino-9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C32H33N5O7/c1-40-22-13-9-20(10-14-22)32(19-7-5-4-6-8-19,21-11-15-23(41-2)16-12-21)43-17-24-26(38)27(42-3)30(44-24)37-18-34-25-28(37)35-31(33)36-29(25)39/h4-16,18,24,26-27,30,38H,17H2,1-3H3,(H3,33,35,36,39)/t24-,26-,27-,30-/m1/s1
Synonyms: 5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-guanosine; DMT-2'-OMe-Gr; 2'-O-Methyl-5'-O-DMT-D-guanosine; 5'-O-Dimethoxytrityl-2'-O-methylguanosine; 5'-O-DMT-2'-O-methyl-D-guanosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methylguanosine

3'-O-Acetyl-5'-O-DMT-5-iodo-2'-O-methyl-uridine

Description: Highly specialized in the field of biomedicine, 3'-O-Acetyl-5'-O-DMT-5-iodo-2'-O-methyl-uridine stands as a critical compound. Its employment primarily revolves around synthesizing nucleotide analogs for antiviral drug development and acting as a probe in biochemical studies concerning RNA. Promising therapeutic applications against viral infections, like HIV and hepatitis B, are attributed to this product.
CAT: BRP-01635
CAS: 1374692-34-8
MF: C33H33IN2O9
MF: 728.53
Purity: ≥95%
Appearance: White Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.55±0.1 g/cm3
InChIKey: FRHDXHYTYBOQIT-BUVRPPHQSA-N
CanonicalSMILES: CC(=O)OC1C(OC(C1OC)N2C=C(C(=O)NC2=O)I)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC
IUPAC Name: [(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(5-iodo-2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-3-yl] acetate
InChI: InChI=1S/C33H33IN2O9/c1-20(37)44-28-27(45-31(29(28)42-4)36-18-26(34)30(38)35-32(36)39)19-43-33(21-8-6-5-7-9-21,22-10-14-24(40-2)15-11-22)23-12-16-25(41-3)17-13-23/h5-18,27-29,31H,19H2,1-4H3,(H,35,38,39)/t27-,28-,29-,31-/m1/s1
Synonyms: 5'-O-(4,4'-dimethoxytrityl)-3'-acetyl-5-Iodo-2'-O-methyl-uridine; 5'-O-DMT-3'-Ac-5-I-2'-OMe-Ur; 5'-O-(4,4'-Dimethoxytrityl)-2'-O-methyl-3'-O-acetyl-5-iodouridine; 5'-​O-​[Bis(4-​methoxyphenyl)​phenylmethyl]​-​5-​iodo-​2'-​O-​methyl-​uridine 3'-​acetate; 5-Iodo-5'-DMT-2'-O-methyl-3'-acetyl-uridine; 3'-O-Acetyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-5-iodo-2'-O-methyluridine
* Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket